Investor portfolio · SEC Form 13F · Q2 2026

Stanley Druckenmiller's portfolio (Duquesne Family Office)

Stanley Druckenmiller ran Duquesne Capital Management for nearly three decades before returning outside capital in 2010. Duquesne Family Office manages his own money.

All investors →
Holdings as of June 30, 2026 Filed with the SEC Aug 14, 2026 Compared with Q1 2026 (Mar 31, 2026) 13F filer: Duquesne Family Office LLC
Reported value$5.21Bas of Jun 30, 2026
Positions959 are listed options
Top 10 holdings45.8%of reported value
New positions48opened in Q2 2026
Added to17more shares
Reduced10fewer shares
Sold out23fully exited

Stanley Druckenmiller's holdings — Q2 2026

sorted by share of reported value · click a column to sort
#Stock% of portfolioValueSharesChange in sharesQ2 2026
1
NTRANatera, Inc.
16.60%
$864.92M 3.19M +122.70K (+4.0%) Added
2
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
5.40%
$281.61M 589.68K +94.40K (+19.1%) Added
3
STMSTMicroelectronics N.V.
4.46%
$232.38M 3.10M +490.00K (+18.8%) Added
4
Invesco Exchange Traded Fd TS&P500 EQL WGTCall
3.35%
$174.68M 821.00K 0 No change
5
INSMINSMED Inc
2.92%
$151.90M 1.42M +270.60K (+23.4%) Added
6
Ishares IncMSCI BRAZIL ETFCall
2.80%
$145.87M 4.23M 0 No change
7
INSMINSMED IncCall
2.76%
$143.94M 1.35M +1.35M New
8
YPFYPF SOCIEDAD ANONIMA
2.74%
$142.73M 3.14M -97.06K (-3.0%) Reduced
9 2.48%
$129.09M 541.60K +495.80K (+1082.5%) Added
10
TBBBBBB FOODS INC
2.32%
$120.92M 2.90M -207.47K (-6.7%) Reduced
11 2.31%
$120.18M 336.30K +336.30K New
12
Ishares IncMSCI BRAZIL ETF
2.27%
$118.55M 3.44M 0 No change
13 2.26%
$117.73M 122.00K +71.30K (+140.6%) Added
14 2.21%
$114.99M 2.20M +2.20M New
15 2.10%
$109.47M 459.30K +259.30K (+129.7%) Added
16 2.07%
$108.08M 794.79K +532.30K (+202.8%) Added
17
SESea Ltd
2.02%
$105.40M 1.10M 0 No change
18 2.01%
$104.63M 743.95K +743.95K New
19
NAMSNewAmsterdam Pharma Co N.V.
2.00%
$104.05M 3.07M 0 No change
20
Ishares TrRUSSELL 2000 ETFCall
1.90%
$99.15M 330.00K +251.00K (+317.7%) Added
21 1.52%
$79.35M 34.90K -3.25K (-8.5%) Reduced
22
RVMDRevolution Medicines, Inc.
1.44%
$74.83M 399.59K +83.73K (+26.5%) Added
23 1.29%
$67.21M 90.00K 0 No change
24
BTDRBitdeer Technologies Group
1.24%
$64.67M 4.07M +4.07M New
25 1.14%
$59.23M 553.55K +176.00K (+46.6%) Added
26 1.08%
$56.48M 603.00K +603.00K New
27 1.02%
$53.00M 126.00K +126.00K New
28 0.99%
$51.46M 982.20K +982.20K New
29 0.93%
$48.70M 299.00K +299.00K New
30
CPNGCoupang, Inc.
0.89%
$46.33M 2.67M 0 No change
31 0.81%
$42.35M 72.90K +72.90K New
32 0.76%
$39.78M 116.65K +116.65K New
33 0.76%
$39.59M 4.22M +1.90M (+82.2%) Added
34
HUTHut 8 Corp.
0.70%
$36.27M 314.15K +314.15K New
35
CDWCDWCall
0.67%
$35.16M 250.00K +250.00K New
36
CAICaris Life Sciences, Inc.
0.65%
$33.76M 1.89M 0 No change
37
Global X FdsGB MSCI AR ETF
0.58%
$30.02M 328.80K -58.60K (-15.1%) Reduced
38 0.57%
$29.63M 632.60K +632.60K New
39 0.55%
$28.59M 67.19K -144.16K (-68.2%) Reduced
40 0.54%
$28.16M 50.00K +50.00K New
41
NUVBNuvation Bio Inc.
0.49%
$25.79M 4.54M 0 No change
42 0.49%
$25.61M 208.90K +49.20K (+30.8%) Added
43 0.49%
$25.43M 184.06K -566.13K (-75.5%) Reduced
44 0.47%
$24.27M 39.50K +39.50K New
45 0.45%
$23.30M 2.78M +1.24M (+80.1%) Added
46
PURRHyperliquid Strategies Inc
0.44%
$23.15M 2.94M +2.94M New
47 0.44%
$22.96M 173.00K +173.00K New
48
RYTMRHYTHM PHARMACEUTICALS, INC.
0.43%
$22.61M 203.62K +203.62K New
49 0.43%
$22.42M 254.40K +254.40K New
50
DAKTDAKTRONICS INC
0.42%
$21.97M 1.12M +560.47K (+99.6%) Added
51
PCTPureCycle Technologies, Inc.
0.42%
$21.75M 2.68M +1.72M (+178.4%) Added
52
SCCOSOUTHERN COPPER CORP/
0.41%
$21.44M 123.06K +1.22K (+1.0%) Added
53 0.41%
$21.38M 41.20K 0 No change
54 0.41%
$21.28M 118.30K +118.30K New
55
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0.41%
$21.18M 625.00K -1.75M (-73.7%) Reduced
56
UUnity Software Inc.
0.41%
$21.11M 738.78K 0 No change
57
AEVAAeva Technologies, Inc.
0.40%
$20.68M 720.17K +720.17K New
58
RIOTRiot Platforms, Inc.
0.40%
$20.67M 754.80K +754.80K New
59 0.39%
$20.52M 125.66K 0 No change
60 0.37%
$19.23M 18.45K +18.45K New
61 0.36%
$18.89M 43.60K +43.60K New
62
DFTXDefinium Therapeutics, Inc.
0.32%
$16.77M 356.60K +356.60K New
63
BLTEBELITE BIO, INC
0.31%
$16.34M 106.10K 0 No change
64
Invesco Exchange Traded Fd TS&P500 EQL WGT
0.30%
$15.83M 74.40K +74.40K New
65
TXG10x Genomics, Inc.
0.30%
$15.46M 403.10K +403.10K New
66 0.29%
$15.26M 56.59K -38.30K (-40.4%) Reduced
67 0.28%
$14.85M 12.38K +12.38K New
68
XENEXenon Pharmaceuticals Inc.
0.28%
$14.40M 238.60K 0 No change
69
OLMAOlema Pharmaceuticals, Inc.
0.24%
$12.35M 986.83K 0 No change
70 0.20%
$10.56M 77.40K +77.40K New
71
RKTRocket Companies, Inc.
0.20%
$10.27M 652.22K +652.22K New
72
BIDUBaidu, Inc.
0.19%
$10.08M 88.20K +88.20K New
73 0.19%
$9.96M 28.09K -78.61K (-73.7%) Reduced
74 0.19%
$9.94M 151.00K +151.00K New
75 0.19%
$9.82M 56.55K +56.55K New
76 0.19%
$9.68M 185.64K -1.31M (-87.6%) Reduced
77 0.18%
$9.63M 19.20K +19.20K New
78 0.18%
$9.58M 50.30K +50.30K New
79 0.18%
$9.15M 22.00K +22.00K New
80
VISTVista Energy, S.A.B. de C.V.
0.16%
$8.59M 134.70K 0 No change
81
SKESkeena Resources Ltd
0.15%
$8.00M 300.20K +300.20K New
82
JBSJBS N.V.
0.15%
$7.77M 655.90K 0 No change
83
GLUEMonte Rosa Therapeutics, Inc.
0.14%
$7.20M 297.60K +297.60K New
84
RLAYRelay Therapeutics, Inc.
0.13%
$6.53M 349.00K +349.00K New
85
DBVTDBV Technologies S.A.
0.12%
$6.29M 383.36K 0 No change
86
CCCCCC Intelligent Solutions Holdings Inc.
0.12%
$6.04M 1.17M +1.17M New
87
UWMCUWM Holdings Corp
0.11%
$5.92M 2.58M +2.58M New
88
NVTSNavitas Semiconductor Corp
0.11%
$5.58M 311.10K +311.10K New
89 0.11%
$5.54M 62.52K 0 No change
90
FTAIFTAI Aviation Ltd.
0.10%
$5.46M 20.20K +20.20K New
91
BEAMBeam Therapeutics Inc.
0.10%
$5.27M 153.60K +153.60K New
92
AURAurora Innovation, Inc.
0.08%
$4.32M 633.70K +633.70K New
93
IRENIREN Ltd
0.08%
$3.98M 87.10K +87.10K New
94
GGALGRUPO FINANCIERO GALICIA SA
0.06%
$2.98M 59.50K +59.50K New
95
WVEWave Life Sciences, Inc.
0.02%
$1.00M 173.00K 0 No change

Put and call options are listed by the manager at the market value of the underlying shares, not the price paid for the options, and a put is a bet on a falling price.

What Stanley Druckenmiller bought and sold in Q2 2026

by number of shares, vs. the 13F for Q1 2026

New positions (48)

StockSharesValue% of portfolio
INSMINSMED IncCall
1.35M$143.94M2.76%
336.30K$120.18M2.31%
2.20M$114.99M2.21%
743.95K$104.63M2.01%
BTDRBitdeer Technologies Group
4.07M$64.67M1.24%
603.00K$56.48M1.08%
126.00K$53.00M1.02%
982.20K$51.46M0.99%
299.00K$48.70M0.93%
72.90K$42.35M0.81%
116.65K$39.78M0.76%
HUTHut 8 Corp.
314.15K$36.27M0.70%
CDWCDWCall
250.00K$35.16M0.67%
632.60K$29.63M0.57%
50.00K$28.16M0.54%
39.50K$24.27M0.47%
PURRHyperliquid Strategies Inc
2.94M$23.15M0.44%
173.00K$22.96M0.44%
RYTMRHYTHM PHARMACEUTICALS, INC.
203.62K$22.61M0.43%
254.40K$22.42M0.43%
118.30K$21.28M0.41%
AEVAAeva Technologies, Inc.
720.17K$20.68M0.40%
RIOTRiot Platforms, Inc.
754.80K$20.67M0.40%
18.45K$19.23M0.37%
43.60K$18.89M0.36%

Plus 23 smaller new positions in the full holdings table.

Sold out (23)

StockShares soldValue in Q1 2026Was % of portfolio
−195.96K$60.65M1.80%
−1.87M$50.30M1.49%
FIGRFigure Technology Solutions, Inc.
−1.15M$39.06M1.16%
QSRRestaurant Brands International Inc.
−454.44K$33.58M0.99%
−323.13K$29.97M0.89%
−137.50K$23.84M0.71%
−181.76K$22.87M0.68%
−82.20K$21.84M0.65%
Ishares S&P Gsci Commodity-UNIT BEN INT
−643.00K$20.74M0.61%
−136.32K$18.47M0.55%
−411.40K$18.16M0.54%
NETCloudflare, Inc.
−52.53K$10.84M0.32%
−131.44K$10.59M0.31%
TWSTTwist Bioscience Corp
−206.00K$9.79M0.29%
−40.40K$9.62M0.28%
CLSCELESTICA INC
−33.27K$9.37M0.28%
STUBStubHub Holdings, Inc.
−1.37M$8.53M0.25%
−23.40K$7.91M0.23%
−60.77K$7.11M0.21%
ALMAlmonty Industries Inc.
−469.88K$6.80M0.20%
−6.96K$4.89M0.14%
−2.77K$4.78M0.14%
−21.19K$2.48M0.07%

Added to (17)

StockShares addedChange% of portfolio
+495.80K+1082.5%2.48%
Ishares TrRUSSELL 2000 ETFCall
+251.00K+317.7%1.90%
+532.30K+202.8%2.07%
+71.30K+140.6%2.26%
+259.30K+129.7%2.10%
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
+94.40K+19.1%5.40%
STMSTMicroelectronics N.V.
+490.00K+18.8%4.46%
NTRANatera, Inc.
+122.70K+4.0%16.60%
INSMINSMED Inc
+270.60K+23.4%2.92%
+176.00K+46.6%1.14%
+1.90M+82.2%0.76%
RVMDRevolution Medicines, Inc.
+83.73K+26.5%1.44%
PCTPureCycle Technologies, Inc.
+1.72M+178.4%0.42%
DAKTDAKTRONICS INC
+560.47K+99.6%0.42%
+1.24M+80.1%0.45%
+49.20K+30.8%0.49%
SCCOSOUTHERN COPPER CORP/
+1.22K+1.0%0.41%

Reduced (10)

StockShares soldChange% of portfolio
-566.13K-75.5%0.49%
-1.31M-87.6%0.19%
-144.16K-68.2%0.55%
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
-1.75M-73.7%0.41%
-78.61K-73.7%0.19%
-38.30K-40.4%0.29%
TBBBBBB FOODS INC
-207.47K-6.7%2.32%
-3.25K-8.5%1.52%
Global X FdsGB MSCI AR ETF
-58.60K-15.1%0.58%
YPFYPF SOCIEDAD ANONIMA
-97.06K-3.0%2.74%

Changes compare share counts in the two filings, so they show net buying or selling over the quarter, not individual trades or prices paid.

How to read a 13F. Investment managers file Form 13F within 45 days after each quarter ends, so these holdings show Duquesne Family Office's positions on June 30, 2026; it may have bought or sold since. The report covers only long positions in US-listed stocks, ETFs, certain convertible bonds and listed options. Short sales, cash, most bonds, private companies and shares traded only outside the US are left out, so a 13F is a partial and delayed view. Percentages are each position's share of the total value reported in the filing, not of the firm's total assets.

Filings behind this page

EDGAR ↗

Frequently asked questions

What is Stanley Druckenmiller's largest holding?

As of June 30, 2026, the largest position in Duquesne Family Office's 13F is Natera, Inc. (NTRA), at 16.6% of the reported portfolio and worth $864.92M. The top 10 positions add up to 45.8% of the $5.21B reported.

What did Stanley Druckenmiller buy and sell in Q2 2026?

Compared with Q1 2026, the Q2 2026 13F shows 48 new positions (largest: INSMED Inc, Alphabet Inc. (Class A), Fox Corporation (Class A)), 17 positions increased, 10 reduced and 23 sold out (largest: Broadcom, Option Care Health, Figure Technology Solutions, Inc.). Changes are measured in shares between the two quarter-end reports.

How current is this portfolio?

Duquesne Family Office's latest 13F was filed on August 14, 2026 and shows holdings as of June 30, 2026. Managers have 45 days after each quarter ends to file, and the next report is due about 45 days after the following quarter end, so positions can be several months old by the time you read them.

Does the 13F show everything Stanley Druckenmiller owns?

No. Form 13F covers long positions in US-listed stocks, ETFs and listed options. Short positions, cash, bonds, private investments and most shares listed only outside the US are not reported, so the 13F is a partial view of the portfolio.

Source: SEC Form 13F filings (Duquesne Family Office LLC, CIK 1536411), as reported by the manager; tickers matched to issuer names by Flash Finance US. Not investment advice.